SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – ‘10-Q’ for 3/31/20

On:  Monday, 5/11/20, at 4:16pm ET   ·   For:  3/31/20   ·   Accession #:  1498068-20-73   ·   File #:  1-37751

Previous ‘10-Q’:  ‘10-Q’ on 11/5/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/10/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 11/6/20 for 9/30/20   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/11/20  American Renal Assocs Holdin… Inc 10-Q        3/31/20   81:9M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.19M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
76: R1          Cover Page                                          HTML     78K 
29: R2          Consolidated Balance Sheets                         HTML    135K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
45: R4          Consolidated Statements of Operations               HTML     88K 
74: R5          Consolidated Statements of Comprehensive Loss       HTML     41K 
27: R6          Consolidated Statement of Changes in Equity         HTML     91K 
19: R7          Consolidated Statements of Cash Flows               HTML    126K 
48: R8          Basis of Presentation and Organization              HTML     39K 
72: R9          Revenue                                             HTML     47K 
14: R10         Assets Held for Sale                                HTML     46K 
36: R11         Fair Value Measurements                             HTML    106K 
60: R12         Accrued Expenses and Other Current Liabilities      HTML     39K 
52: R13         Variable Interest Entities                          HTML     30K 
15: R14         Noncontrolling Interests Subject to Put Provisions  HTML     52K 
37: R15         Debt                                                HTML     85K 
61: R16         Leases                                              HTML    254K 
53: R17         Income Taxes                                        HTML     30K 
13: R18         Stock-Based Compensation                            HTML     73K 
38: R19         Loss Per Share                                      HTML     40K 
78: R20         Related Party Transactions                          HTML     45K 
50: R21         Commitments and Contingencies                       HTML     28K 
24: R22         Certain Legal and Other Matters                     HTML     50K 
32: R23         Changes in Ownership Interest in Consolidated       HTML     35K 
                Subsidiaries                                                     
79: R24         Recent and Subsequent Events                        HTML     43K 
51: R25         Basis of Presentation and Organization (Policies)   HTML     45K 
25: R26         Revenue (Tables)                                    HTML     34K 
33: R27         Assets Held for Sale (Tables)                       HTML     47K 
80: R28         Fair Value Measurements (Tables)                    HTML     98K 
49: R29         Accrued Expenses and Other Current Liabilities      HTML     40K 
                (Tables)                                                         
55: R30         Noncontrolling Interests Subject to Put Provisions  HTML     48K 
                (Tables)                                                         
64: R31         Debt (Tables)                                       HTML     52K 
35: R32         Leases (Tables)                                     HTML    187K 
12: R33         Stock-Based Compensation (Tables)                   HTML     69K 
54: R34         Loss Per Share (Tables)                             HTML     39K 
63: R35         Changes in Ownership Interest in Consolidated       HTML     36K 
                Subsidiaries (Tables)                                            
34: R36         Basis of Presentation and Organization (Details)    HTML     40K 
11: R37         Revenue (Details)                                   HTML     44K 
56: R38         ASSETS HELD FOR SALE - Narrative (Details)          HTML     44K 
62: R39         FAIR VALUE MEASUREMENTS - Schedule of fair values   HTML     73K 
                (Details)                                                        
43: R40         ASSETS HELD FOR SALE - Schedule of assets and       HTML     58K 
                liabilities held for sale (Details)                              
71: R41         FAIR VALUE MEASUREMENTS - Fair value rollforward    HTML     32K 
                for tax receivable agreement liability (Details)                 
31: R42         FAIR VALUE MEASUREMENTS - Narrative (Details)       HTML     31K 
23: R43         Accrued Expenses and Other Current Liabilities      HTML     43K 
                (Details)                                                        
41: R44         Variable Interest Entities (Details)                HTML     30K 
70: R45         Noncontrolling Interests Subject to Put Provisions  HTML     54K 
                (Details)                                                        
30: R46         DEBT - Schedule of long-term debt (Details)         HTML     50K 
22: R47         DEBT - Scheduled maturities of long-term debt       HTML     43K 
                (Details)                                                        
44: R48         DEBT - Narrative (Details)                          HTML    155K 
69: R49         LEASES - Narrative (Details)                        HTML     49K 
66: R50         LEASES - Lease Cost (Details)                       HTML     40K 
58: R51         LEASES LEASES - Supplemental Cash Flow Related to   HTML     37K 
                Leases (Details)                                                 
16: R52         LEASES LEASES - Supplemental Balance Sheet Related  HTML     59K 
                to Leases (Details)                                              
39: R53         LEASES - Future Minimum Lease Payments Under        HTML    101K 
                Noncancelable Leases - For Period Ending March 31,               
                2020 (Details)                                                   
67: R54         LEASES - Future Minimum Lease Payments Under        HTML    101K 
                Noncancelable Leases - For Period Ending December                
                31, 2019 (Details)                                               
59: R55         Income Taxes (Details)                              HTML     33K 
17: R56         STOCK-BASED COMPENSATION - Schedule of Expense      HTML     33K 
                (Details)                                                        
40: R57         STOCK-BASED COMPENSATION - Narrative (Details)      HTML     76K 
68: R58         STOCK-BASED COMPENSATION STOCK-BASED COMPENSATION   HTML     38K 
                - Assumptions used for options granted (Details)                 
57: R59         STOCK-BASED COMPENSATION - Option activity          HTML     58K 
                (Details)                                                        
18: R60         STOCK-BASED COMPENSATION - Restricted stock awards  HTML     48K 
                (Details)                                                        
26: R61         Loss Per Share (Details)                            HTML     46K 
75: R62         Related Party Transactions (Details)                HTML     94K 
46: R63         Commitments and Contingencies (Details)             HTML     24K 
20: R64         Certain Legal and Other Matters (Details)           HTML     57K 
28: R65         Changes in Ownership Interest in Consolidated       HTML     35K 
                Subsidiaries (Details)                                           
77: R66         Recent and Subsequent Events (Details)              HTML     47K 
47: XML         IDEA XML File -- Filing Summary                      XML    145K 
81: XML         XBRL Instance -- ara-3312020x10q_htm                 XML   1.99M 
73: EXCEL       IDEA Workbook of Financial Reports                  XLSX     93K 
 7: EX-101.CAL  XBRL Calculations -- ara-20200331_cal                XML    324K 
 8: EX-101.DEF  XBRL Definitions -- ara-20200331_def                 XML    608K 
 9: EX-101.LAB  XBRL Labels -- ara-20200331_lab                      XML   1.94M 
10: EX-101.PRE  XBRL Presentations -- ara-20200331_pre               XML   1.09M 
 6: EX-101.SCH  XBRL Schema -- ara-20200331                          XSD    189K 
65: JSON        XBRL Instance as JSON Data -- MetaLinks              396±   600K 
42: ZIP         XBRL Zipped Folder -- 0001498068-20-000073-xbrl      Zip    332K 




        
Filing Submission 0001498068-20-000073 – SGML Text

Original SGML Text submitted by:  American Renal Associates Holdings, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:10:42.2am ET